Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation

• Publication date

  2003-11-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000093196.59829.DFPMID 14568902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in the expression of cytochrome c oxidase subunits in doxorubicin-resistant leukemia K562 cells.

  2002cited by this paper
• Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.

  2002cited by this paper
• Evidence of Nucleoside Analogue Reverse Transcriptase Inhibitor‐Associated Genetic and Structural Defects of Mitochondria in Adipose Tissue of HIV‐Infected Patients

  2002cited by this paper
• Skeletal muscle training in chronic heart failure.

  2001cited by this paper
• Doxorubicin-Induced Cardiomyopathy

  2000cited by this paper
• Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration.

  1999cited by this paper
• Doxorubicin-induced cardiomyopathy.

  1998cited by this paper
• Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

  1998cited by this paper
• Long-Lasting Effect of Dexrazoxane Against Anthracycline Cardiotoxicity in Rats

  1996cited by this paper
• Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells.

  1995cited by this paper
• Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

  1995cited by this paper
• Detection and quantitation by competitive PCR of an age-associated increase in a 4.8-kb deletion in rat mitochondrial DNA.

  1994cited by this paper
• A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity.

  1993cited by this paper
• Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine.

  1992cited by this paper
• Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR).

  1991cited by this paper
• Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease.

  1991cited by this paper
• Progressive Increase of the Mutated Mitochondrial DNA Fraction in Kearns-Sayre Syndrome

  1990cited by this paper
• Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.

  1990cited by this paper
• A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA.

  1989cited by this paper
• Demonstration of the existence of an organo-specific NADH dehydrogenase in heart mitochondria.

  1987cited by this paper
• Comparison of adriamycin uptake in chick embryo heart and liver cells an murine L5178Y lymphoblasts in vitro: role of drug uptake in cardiotoxicity.

  1986cited by this paper
• Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency.

  1980cited by this paper

• Non-Coding RNAs in the Regulation of Doxorubicin-Induced Cardiotoxicity

  2025cites this paper
• Doxorubicin-induced sinus node dysfunction associated with mitochondria and nuclear impairment in a mouse model

  2025cites this paper
• Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.

  2025cites this paper
• Anthracyclines effect on mitochondrial function and biogenesis in normal blood cells of hodgkin lymphoma patients

  2025cites this paper
• Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemia

  2025influential citation
• Tiny genome with big impact: mitochondrial DNA in cardiovascular health.

  2025cites this paper
• Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management

  2024cites this paper
• Inflammation in Chemotherapy-Induced Cardiotoxicity

  2024cites this paper
• Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase

  2024cites this paper
• Cardiotoxicity of Anthracyclines.

  2024cites this paper
• AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway

  2024cites this paper
• Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes.

  2024cites this paper
• Role of mesenchymal stem cells‐derived exosomes on inflammation, apoptosis, fibrosis and telocyte modulation in doxorubicin‐induced cardiotoxicity: A closer look at the structural level

  2024cites this paper
• The interplay between doxorubicin chemotherapy, antioxidant system, and cardiotoxicity: Unrevealing of the protective potential of tannic acid

  2024cites this paper
• Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease

  2024cites this paper
• RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO

  2023cites this paper
• Cardiovascular Aging: Spotlight on Mitochondria.

  2023cites this paper
• Cardio-oncology for Pediatric and Adolescent/Young Adult Patients

  2023cites this paper
• ANALYSIS OF DOXORUBICIN-INDUCED MITOCHONDRIAL DNA DELETIONS IN HUMAN BLOOD LEUKOCYTES AND THP-1 CELL LINE BY PCR

  2023cites this paper
• Biomimetic Nanozymes Suppressed Ferroptosis to Ameliorate Doxorubicin-Induced Cardiotoxicity via Synergetic Effect of Antioxidant Stress and GPX4 Restoration

  2023cites this paper
• Carvedilol Phenocopies PGC-1α Overexpression to Alleviate Oxidative Stress, Mitochondrial Dysfunction and Prevent Doxorubicin-Induced Toxicity in Human iPSC-Derived Cardiomyocytes

  2023cites this paper
• Protective effect of urotensin II receptor antagonist urantide and exercise training on doxorubicin-induced cardiotoxicity

  2023cites this paper
• Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity

  2023cites this paper
• The fate of damaged mitochondrial DNA in the cell.

  2022cites this paper
• Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo‐ and radiotherapy for early breast cancer

  2022cites this paper
• Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches

  2022cites this paper
• Cardiovascular Risk in Childhood Cancer Survivors

  2022cites this paper
• Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity

  2022cites this paper
• Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay

  2022cites this paper
• Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress.

  2022cites this paper
• Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.

  2021cites this paper
• The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases

  2021cites this paper
• Building Multi-Dimensional Induced Pluripotent Stem Cells-Based Model Platforms to Assess Cardiotoxicity in Cancer Therapies

  2021cites this paper
• Mitochondrial nucleoid in cardiac homeostasis: bidirectional signaling of mitochondria and nucleus in cardiac diseases

  2021cites this paper
• Cardiotoxicity in pediatric lymphoma survivors

  2021cites this paper
• Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.

  2021cites this paper
• ATVB IN FOCUS: Cardiovascular Effects of Anticancer Treatments/Agents

  2021cites this paper
• Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets

  2020cites this paper
• Cardiovascular Research

  2020cites this paper
• Association of mitochondrial DNA content and displacement loop region sequence variations with cancer-related fatigue in breast cancer survivors receiving chemotherapy.

  2020cites this paper
• Cellular targets of oxidative stress

  2020cites this paper
• PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1

  2020cites this paper
• Preventing and Treating Anthracycline Cardiotoxicity: New Insights.

  2020cites this paper
• Age-Related Considerations in Cardio-Oncology

  2020cites this paper
• Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.

  2020cites this paper
• Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation

  2020cites this paper
• Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.

  2020cites this paper
• Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity.

  2020cites this paper
• Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging

  2020cites this paper
• Complications cardiaques des traitements anticancéreux

  2020cites this paper
• Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

  2020cites this paper
• Effect of TFAM on ATP content in tachypacing primary cultured cardiomyocytes and atrial fibrillation patients

  2020cites this paper
• The Etiology and Impact of Muscle Wasting in Metastatic Cancer.

  2020cites this paper
• The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine

  2020cites this paper
• Doxorubicin-Induced Cardiomyopathy in Children.

  2019cites this paper
• Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature.

  2019cites this paper
• p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities

  2019cites this paper
• Doxorubicin-Immersed Skeletal Muscle Grafts Promote Peripheral Nerve Regeneration Across a 10-mm Defect in the Rat Sciatic Nerve

  2019cites this paper
• Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.

  2019cites this paper
• Erratum: Doxorubicin-Immersed Skeletal Muscle Grafts Promote Peripheral Nerve Regeneration Across a 10-mm Defect in the Rat Sciatic Nerve

  2019cites this paper
• Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors

  2019cites this paper
• Breast Cancer and Heart Failure.

  2019cites this paper
• Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?

  2019cites this paper
• Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle.

  2019cites this paper
• Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway

  2019cites this paper
• MiR-378 modulates energy imbalance and apoptosis of mitochondria induced by doxorubicin.

  2018cites this paper
• The cardioprotective effect of dexrazoxane (Cardioxane) is consistent with sequestration of poly(ADP-ribose) by self-assembly and not depletion of topoisomerase 2B

  2018cites this paper
• Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review.

  2018cites this paper
• Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib

  2018cites this paper
• Drug‐Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children

  2018cites this paper
• Multi-Tissue Examination of Exercise or Metformin on the Consequences of Doxorubicin Treatment

  2018cites this paper
• Improving Aav Transduction Efficiency In Retinal Bipolar Cells For Optogenetic Vision Restoration

  2018cites this paper
• Cardiogenic Shock 14 Years Post Anthracyclines

  2018cites this paper
• Fluoride induced tissue hypercalcemia, IL-17 mediated inflammation and apoptosis lead to cardiomyopathy: Ultrastructural and biochemical findings.

  2018cites this paper
• sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats

  2018cites this paper
• Effect of fermented Cordyceps sinensis on doxorubicin-induced cardiotoxicity in rats

  2018influential citation
• Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer.

  2018cites this paper
• Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.

  2017cites this paper
• Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects

  2017cites this paper
• Acute and chronic effects of anti-cancer agents on cardiac mitochondrial function

  2017influential citation
• Mitochondrial cardiomyopathies feature increased uptake and diminished efflux of mitochondrial calcium.

  2017cites this paper
• Chemotherapy-induced cardiotoxicity in children

  2017cites this paper
• Electronic Theses and Dissertations Title Importance of Mitochondrial Homeostasis in Heart Disease and Its Prevention

  2017cites this paper
• Importance of Mitochondrial Homeostasis in Heart Disease and Its Prevention

  2017cites this paper
• Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.

  2017cites this paper
• Heart Failure in Pediatric Oncologic Disease

  2017cites this paper
• Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation

  2017cites this paper
• Effects of doxorubicin administration on bone strength and quality in sedentary and physically active Wistar rats

  2016cites this paper
• Cardiovascular Effects of Anthracycline Chemotherapy and Radiation Therapy in Children with Cancer

  2016cites this paper
• Mitochondrial pathways to cardiac recovery: TFAM

  2016cites this paper
• Developing micro and nanostrategies for human cancer detection and therapy

  2016cites this paper
• Current views on anthracycline cardiotoxicity

  2016cites this paper
• Sirt 3 protects mitochondrial DNA damage and blocks the development of doxorubicin-1 induced cardiomyopathy in Mice 2 3 4 5

  2016cites this paper
• A Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial Cardiotoxicity

  2016influential citation
• Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection

  2016cites this paper
• Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin‐treated childhood acute lymphoblastic leukemia survivors

  2016influential citation
• Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes

  2016cites this paper
• Pathophysiology of anthracycline cardiotoxicity

  2016cites this paper
• Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.

  2016cites this paper
• An experimental approach to study the function of mitochondria in cardiomyopathy

  2015cites this paper